Drugmakers received grand jury subpoenas from the U.S. Justice Dept. this week in connection with an antitrust probe into companies that market intravenous saline solutions.
ICU Medical (NSDQ:ICUI), which recently acquired Hospira Infusion Systems from Pfizer (NYSE:PFE), and Baxter (NYSE:BAX) disclosed the subpoenas this week. Pfizer revealed that it is also wrapped up in the investigation, according to Reuters.
Get the full story at our sister site, Drug Delivery Business News.
The post Hospira, Baxter subpoenaed in antitrust probe over intravenous saline appeared first on MassDevice.